The Seattle Times

GLP-1 weight-loss drugs will be covered for fewer U.S. employees

As healthcare costs surge, a growing number of U.S. employers are dropping coverage for expensive weight-loss GLP-1 medications, sparking significant backlash from employees across the country.

Read the original at The Seattle Times

More audio from The Seattle Times